Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of PT003, PT005, and PT001 in Moderate to Very Severe COPD
NCT02343458Phase 3Completed
- Sponsor
- Pearl Therapeutics
- Start
- Mar 2015
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of BEVESPI AEROSPHERE in chronic obstructive pulmonary disease (COPD), sponsored by Pearl Therapeutics. Started Mar 2015; status: completed.
02
Drugs
BEVESPI AEROSPHERE
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02343458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02343458.